SD

Sangadala Devi

Active Director Director DIN 11031834
DIN 11031834 First appointment Apr 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sangadala Devi

Data last updated:

Sangadala Devi is a Director at Lito Biosciences Private Limited (since 2025). The company operates in Biotechnology.

DIN 11031834
Primary Designation Director
Industry Biotechnology
First Appointment 01 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lito Biosciences Private Limited U46692AP2025PTC118610
Director01 Apr 20252025Active

Board colleagues of Sangadala Devi

NameDINCompanyDesignation
Rezeena Kodavati10578719Lito Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lito Biosciences Private Limited
Premium access

Shareholding and investment profile for Sangadala Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangadala Devi

Sangadala Devi currently holds 1 directorship: Lito Biosciences Private Limited (Director, since 01 Apr 2025).

Sangadala Devi was first appointed on 01 Apr 2025 as Director at Lito Biosciences Private Limited.

The current boards of Sangadala Devi's companies include Rezeena Kodavati (Lito Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available